Recombinant Human Thymosin Beta 4 Injection (NL005)
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant Human Thymosin Beta 4 Injection (NL005) for st elevation myocardial infarction | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |